Research community previously filed under “Pharmaceutical Science”

Cyclodextrin Inclusion Complexes and Pharmaceutical Formulation Development

Mostly in the field Surfactant Chemistry, Inclusion Complexes, and Environmental Applications (27% of its papers), one of 4 communities there

Papers 5,763
Elements —
Keywords & sectors 1
Leading venue International Journal of Pharmaceutics

Cyclodextrin Inclusion Complexes and Pharmaceutical Formulation Development

This community focuses on the design, synthesis, and evaluation of cyclodextrin-based inclusion complexes to enhance the solubility, stability, and delivery of pharmaceutical agents, as well as the formulation of solid dosage forms like tablets.

The work centers on the chemical modification of cyclodextrins to create host-guest systems that encapsulate poorly soluble drugs. Recurring applications include improving the bioavailability of specific compounds such as diclofenac sodium, losartan potassium, and trospium chloride. Methodologies frequently involve physicochemical characterization, thermal stability testing, and analytical techniques like capillary electrophoresis and liquid chromatography. The research also covers the development of solid dosage forms through direct compression and the use of excipients like magnesium stearate. While a subset of papers addresses "energy healing" and "biofield energy," the dominant technical strand is the supramolecular chemistry of cyclodextrin derivatives for drug delivery and formulation optimization.

The largest share of the community's output is found in sodium research, accounting for 0.2% of all sodium research, and 691 papers here. Magnesium and potassium research also feature prominently, with 433 and 290 papers respectively.

The community comprises 5,763 papers, publishing primarily in the International Journal of Pharmaceutics, Pharmaceutics, and the Journal of Pharmaceutical Sciences.

Recent work continues to focus on cyclodextrin applications in drug delivery, including the encapsulation of polyphenols and the development of supramolecular self-assemblies. There is also ongoing clinical research into the long-term efficacy and safety of xanomeline and trospium chloride for schizophrenia, alongside investigations into cyclodextrins as active therapeutic agents and their use in cosmetic and food industries.

Recurring themes in the literature

Phrases that recur across this community's paper titles -- a quick map of its sub-topics, drawn straight from the titles themselves.

  • drug delivery 118
  • inclusion complexes 106
  • biofield energy 80
  • diclofenac sodium 76
  • energy healing 68
  • cyclodextrin inclusion 66
  • losartan potassium 62
  • magnesium stearate 57
  • consciousness energy 53
  • inclusion complex 53
  • energy treated 45
  • delivery system 39
  • host guest 39
  • delivery systems 38
  • capillary electrophoresis 37
  • liquid chromatography 37
  • healing treatment 36
  • formulation evaluation 35
  • test formulation 35
  • trospium chloride 33
  • dry powder 32
  • physicochemical thermal 31
  • xanomeline trospium 31
  • mass spectrometry 30

Papers behind this description

Most cited
Pharmaceutics · 2025 · 146 citations
Carbohydrate Polymers · 2023 · 274 citations
JAMA Psychiatry · 2024 · 183 citations
Molecules · 2024 · 119 citations
Pharmaceutics · 2025 · 83 citations
Newest
Molecules · 2025 · 18 citations
Pharmaceuticals · 2025 · 16 citations
Carbohydrate Polymers · 2025 · 15 citations
Schizophrenia Research · 2026 · 11 citations
American Journal of Psychiatry · 2026 · 10 citations

A sample from the 18 papers behind this description. Create a free account to see them all.